Interpace Biosciences Inc IDXG
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if IDXG is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- $1.55
- Day Range
- $1.42–1.43
- 52-Week Range
- $0.62–3.54
- Bid/Ask
- $1.43 / $1.70
- Market Cap
- $6.23 Mil
- Volume/Avg
- 2,178 / 6,560
Key Statistics
- Price/Earnings (Normalized)
- 2.87
- Price/Sales
- 0.17
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- 0.47%
Company Profile
Interpace Biosciences Inc is a fully integrated commercial company. It provides molecular diagnostics, bioinformatics and pathology services for evaluation of risk of cancer by leveraging the latest technology in personalized medicine for improved patient diagnosis and management. The company develops and commercializes genomic tests and related first line assays principally focused on early detection of patients with indeterminate biopsies and at high risk of cancer using the latest technology.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Value
- Total Number of Employees
- 108
- Website
- https://www.interpace.com
Valuation
|
Metric
|
IDXG
|
|---|---|
Price/Earnings (Normalized) | 2.87 |
Price/Book Value | — |
Price/Sales | 0.17 |
Price/Cash Flow | 1.75 |
Price/Earnings
IDXG
Financial Strength
|
Metric
|
IDXG
|
|---|---|
Quick Ratio | 0.49 |
Current Ratio | 0.59 |
Interest Coverage | 2.12 |
Quick Ratio
IDXG
Profitability
|
Metric
|
IDXG
|
|---|---|
Return on Assets (Normalized) | 11.59% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
IDXG
Diagnostics & Research Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
TMO
| Thermo Fisher Scientific Inc | Nfvpjpnd | Mwby | $209.3 Bil | |
DHR
| Danaher Corp | Qlsbmnkrrc | Nzplwl | $185.5 Bil | |
IQV
| IQVIA Holdings Inc | Mdjpjzktb | Kfgnj | $43.4 Bil | |
IDXX
| IDEXX Laboratories Inc | Fvqrftmwcj | Gmlzc | $41.0 Bil | |
A
| Agilent Technologies Inc | Jbkydwhd | Tqsq | $40.3 Bil | |
MTD
| Mettler-Toledo International Inc | Lpsxcwjh | Ztsdcp | $26.4 Bil | |
ICLR
| Icon PLC | Gdkvncb | Klbvtbc | $25.2 Bil | |
ILMN
| Illumina Inc | Vsmpzyqgc | Jkkmj | $19.6 Bil | |
WAT
| Waters Corp | Sghkqwpmt | Cjkr | $18.0 Bil | |
LH
| Laboratory Corp of America Holdings | Mrnlwtrtc | Zbhvgk | $17.5 Bil |